Additionally, Stracquadanio et al. reported that CD44 genetic variant rs187115 could be identified as a diagnostic biomarker for pancreatic ductal adenocarcinoma and was associated with tumor progression 21. Here, CD44 is linked to pancreatic ductal adenocarcinoma.